SCH772984 is an ATP Competitive and Non-Competitive ERK1 and ERK2 Inhibitor
Specific inhibitors of RAF and MEK kinases to target BRAF- and RAS-mutant tumors are developing. Interestingly, BRAF/MEK inhibitor combination treatment blocks phosphorylated extracellular signal-regulated kinase (phospho-ERK) reactivation in melanoma cells, a…